Article Details
Retrieved on: 2021-03-10 15:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Valneva and Pfizer are getting set to launch a new Phase 2 study on VLA-15, their vaccine candidate for Lyme disease. The study, VLA15-221, builds ...
Article found on: homelandprepnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here